Results summary | View all lists in L2L MDB | View all genes in G02C.profile.u50 |
Reduced expression in XPC-defective fibroblasts, compared to normal fibroblasts, following treatment with cisplatin enrichment: 5.57-fold |
![]() |
![]() | |||||||||||
Probe ID | Name | G | T | D | X | E | P | R | C | S | ![]() |
![]() |
Description |
200921_S_AT | BTG1 | G | D | R | ![]() |
![]() |
B-cell translocation gene 1, anti-proliferative | ||||||
203140_AT | BCL6 | G | D | X | R | C | S | ![]() |
![]() |
B-cell CLL/lymphoma 6 (zinc finger protein 51) | |||
211559_S_AT | CCNG2 | ![]() |
![]() |
cyclin G2 | |||||||||
209435_S_AT | ARHGEF2 | G | T | P | S | ![]() |
![]() |
rho/rac guanine nucleotide exchange factor (GEF) 2 | |||||
205128_X_AT | PTGS1 | E | ![]() |
![]() |
prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |